sulforaphane has been researched along with Arthritis, Degenerative in 5 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sulforaphane (SFN) is an isothiocyanate with anti-arthritic and immuno-regulatory activities, supported by the downregulation of NF-κB pathway, reduction on metalloproteinases expression and prevention of cytokine-induced cartilage degeneration implicated in OA progression." | 5.62 | Sulforaphane-loaded hyaluronic acid-poloxamer hybrid hydrogel enhances cartilage protection in osteoarthritis models. ( Alberto-Silva, C; Ambrosio, FN; Christoffolete, MA; de Araujo, DR; Ferraraz, DC; Franco, MKKD; Kent, B; Lombello, CB; Monteiro do Nascimento, MH; Nascimento-Sales, M; Querobino, SM; Windisch-Neto, H; Yokaichiya, F, 2021) |
| "Sulforaphane is a naturally occurring antioxidant." | 5.46 | Stable sulforaphane protects against gait anomalies and modifies bone microarchitecture in the spontaneous STR/Ort model of osteoarthritis. ( Aljazzar, A; Chan, B; Chang, YM; de Souza, R; Hopkinson, M; Javaheri, B; Lee, PD; Orriss, IR; Piles, M; Pitsillides, AA; Pollard, A; Poulet, B; Shervill, E, 2017) |
| "Sulforaphane (SFN) is a member of the isothiocyanate family that has anti-inflammatory action as well as anti-carcinogenic properties." | 5.39 | Sulforaphane-PLGA microspheres for the intra-articular treatment of osteoarthritis. ( Choi, YJ; Im, GI; Jeong, GJ; Ko, JY, 2013) |
| "Sulforaphane (SFN) is an isothiocyanate with anti-arthritic and immuno-regulatory activities, supported by the downregulation of NF-κB pathway, reduction on metalloproteinases expression and prevention of cytokine-induced cartilage degeneration implicated in OA progression." | 1.62 | Sulforaphane-loaded hyaluronic acid-poloxamer hybrid hydrogel enhances cartilage protection in osteoarthritis models. ( Alberto-Silva, C; Ambrosio, FN; Christoffolete, MA; de Araujo, DR; Ferraraz, DC; Franco, MKKD; Kent, B; Lombello, CB; Monteiro do Nascimento, MH; Nascimento-Sales, M; Querobino, SM; Windisch-Neto, H; Yokaichiya, F, 2021) |
| "Sulforaphane is a naturally occurring antioxidant." | 1.46 | Stable sulforaphane protects against gait anomalies and modifies bone microarchitecture in the spontaneous STR/Ort model of osteoarthritis. ( Aljazzar, A; Chan, B; Chang, YM; de Souza, R; Hopkinson, M; Javaheri, B; Lee, PD; Orriss, IR; Piles, M; Pitsillides, AA; Pollard, A; Poulet, B; Shervill, E, 2017) |
| "Sulforaphane (SFN) is a member of the isothiocyanate family that has anti-inflammatory action as well as anti-carcinogenic properties." | 1.39 | Sulforaphane-PLGA microspheres for the intra-articular treatment of osteoarthritis. ( Choi, YJ; Im, GI; Jeong, GJ; Ko, JY, 2013) |
| "Sulforaphane (SFN) has been reported to regulate signaling pathways relevant to chronic diseases." | 1.39 | Sulforaphane represses matrix-degrading proteases and protects cartilage from destruction in vitro and in vivo. ( Bao, Y; Clark, IM; Culley, KL; Davidson, RK; de Ferrars, R; Donell, ST; Driscoll, C; Jupp, O; Kay, CD; Norton, R; Vincent, TL, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Monteiro do Nascimento, MH | 1 |
| Ambrosio, FN | 1 |
| Ferraraz, DC | 1 |
| Windisch-Neto, H | 1 |
| Querobino, SM | 1 |
| Nascimento-Sales, M | 1 |
| Alberto-Silva, C | 1 |
| Christoffolete, MA | 1 |
| Franco, MKKD | 1 |
| Kent, B | 1 |
| Yokaichiya, F | 1 |
| Lombello, CB | 1 |
| de Araujo, DR | 1 |
| Javaheri, B | 1 |
| Poulet, B | 1 |
| Aljazzar, A | 1 |
| de Souza, R | 1 |
| Piles, M | 1 |
| Hopkinson, M | 1 |
| Shervill, E | 1 |
| Pollard, A | 1 |
| Chan, B | 1 |
| Chang, YM | 1 |
| Orriss, IR | 1 |
| Lee, PD | 1 |
| Pitsillides, AA | 1 |
| Ko, JY | 1 |
| Choi, YJ | 1 |
| Jeong, GJ | 1 |
| Im, GI | 1 |
| Davidson, RK | 1 |
| Jupp, O | 1 |
| de Ferrars, R | 1 |
| Kay, CD | 1 |
| Culley, KL | 1 |
| Norton, R | 1 |
| Driscoll, C | 1 |
| Vincent, TL | 1 |
| Donell, ST | 1 |
| Bao, Y | 1 |
| Clark, IM | 1 |
| Pal, S | 1 |
| Konkimalla, VB | 1 |
5 other studies available for sulforaphane and Arthritis, Degenerative
| Article | Year |
|---|---|
Sulforaphane-loaded hyaluronic acid-poloxamer hybrid hydrogel enhances cartilage protection in osteoarthritis models.
Topics: Cartilage; Humans; Hyaluronic Acid; Hydrogels; Isothiocyanates; Osteoarthritis; Poloxamer; Sulfoxide | 2021 |
Stable sulforaphane protects against gait anomalies and modifies bone microarchitecture in the spontaneous STR/Ort model of osteoarthritis.
Topics: Animals; Antioxidants; Arthritis, Experimental; Bone and Bones; Isothiocyanates; Lameness, Animal; M | 2017 |
Sulforaphane-PLGA microspheres for the intra-articular treatment of osteoarthritis.
Topics: Aged; Animals; Cartilage, Articular; Chondrocytes; Cytoprotection; Dose-Response Relationship, Drug; | 2013 |
Sulforaphane represses matrix-degrading proteases and protects cartilage from destruction in vitro and in vivo.
Topics: Animals; Arthritis, Experimental; Cartilage, Articular; Cattle; Chondrocytes; Humans; Isothiocyanate | 2013 |
Sulforaphane regulates phenotypic and functional switching of both induced and spontaneously differentiating human monocytes.
Topics: Anti-Inflammatory Agents; Arthritis, Experimental; Cell Differentiation; Cell Line; Collagen; Extrac | 2016 |